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Abbreviations and acronyms:  1 
AB: Antibiotic; AUC: Area under the curve; AUROC: AUC area under the ROC curve; CD-ERI: 2 
clinically diagnosed EVD related infection, CP-ERI: culture-proven EVD related infection, CSF 3 
WBCC: CSF white blood cell count; CNS: central nervous system; CoNS: Coagulase-Negative 4 
Staphylococci; CRP: C-reactive protein; CSF: cerebrospinal fluid; ERI: EVD-related infection; 5 
EVD: external ventricular drain; GCS: Glasgow Coma Score; GOS: Glasgow Outcome Score; 6 
ICH: intracerebral haemorrhage; ICP: intracerebral pressure; ICU: intensive care unit; LOS: 7 
length of hospital stay; PMN: Polymorphonuclear Neutrophils; RBC: red blood cell; RBCC: red 8 
blood cell count; ROC: Receiver operating characteristic; S-CRP: serum C-reactive protein; S-9 
WBCC: Serum white blood cell count; SAH: subarachnoid haemorrhage; SIRS: systemic 10 
inflammatory response syndrome; TBI: Traumatic brain injury; WBC: White Blood Cell  11 
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Abstract: 1 
 2 
Background: Device infection is a major complication of placement external ventricular drains 3 
(EVD). Diagnostic features are often masked by underlying disease or cerebrospinal fluid (CSF) 4 
contamination by blood. We aim to assess which diagnostic modalities are applied for EVD-5 
related infection (ERI) diagnosis and evaluate their accuracy.  6 
Methods: This observational prospective study included 187 adult patients with an EVD. 7 
Modalities of clinical diagnosis of ERI diagnosed by treating physicians on clinical grounds and 8 
blood and CSF analysis (CD-ERI) were assessed prospectively. Additionally, the diagnostic 9 
accuracy of clinical and laboratory parameters for the diagnosis of culture proven ERI (CP-ERI) 10 
was evaluated, using data of the study patients and including a retrospective cohort of 39 11 
patients with culture-proven ERI (CP-ERI). 12 
Results: Thirty-one CD-ERIs were diagnosed in the prospective cohort. Most physicians used 13 
CSF analysis to establish the diagnosis. ROC analysis revealed an AUC of 0.575 (p=0.0047) for 14 
the number of positive SIRS criteria and AUC of 0.5420 (p= 0.11) for the number of 15 
pathological neurological signs for diagnosis of CP-ERI. Diagnostic accuracy of laboratory 16 
values was AUC 0.596 (p=0.0006) for serum white blood cell count (WBCC), AUC 0.550 17 
(p=0.2489) for serum CRP, AUC 0.644 (p< 0.0001) for CSF WBCC and AUC 0.690 for CSF 18 
WBC/red blood cell count ratio (both p< 0.0001). Neither a temporal trend in potential 19 
predictors of CP-ERI nor a correlation between clinical diagnosis and proven CSF infection was 20 
found. 21 
Conclusions: Clinicians base their diagnosis of ERI mostly on CSF analysis and occurrence of 22 
fever, leading to over-diagnosis. The accuracy of the clinical diagnosis is low. Commonly used 23 
clinical and laboratory diagnostic criteria have a low sensitivity and specificity for ERI. 24 
 25 
Key words: External Ventricular Device, EVD-related infection, diagnosis, CSF changes 26 
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Introduction: 1 
The insertion of an external ventricular drain (EVD) is a common and potentially lifesaving 2 
procedure in neurocritical care[9]. EVDs are often used for monitoring of intracerebral 3 
pressure (ICP) and drainage of cerebrospinal fluid (CSF) in the context of intracerebral 4 
haemorrhage (ICH), subarachnoid haemorrhage (SAH) and traumatic brain injury (TBI)[2,37]. 5 
EVD-related Infection (ERI) is one of the major complications of EVD placement, representing 6 
a serious hospital-acquired infection. Reported incidences of EVD-related infections range 7 
from 5% to more than 20% of EVD-placements [1,4,8,18,38,2,10,15,23,25,27] and are 8 
associated with poorer neurological outcomes, increased healthcare costs and prolonged 9 
hospital stays [16,10,15,23-25,27]. 10 
Rapidly available parameters for the diagnosis of ERI include clinical signs such as fever, 11 
nuchal rigidity and a change in mental status, blood tests including elevated white blood cell 12 
(WBC) count, neutrophilia with a shift towards immature band forms or elevated serum C - 13 
reactive protein (CRP)[3] and altered CSF parameters – such as increases in CSF white blood 14 
cell count (CSF WBCC). However, clinical features of EVD-related central nervous system 15 
infection are often masked by an altered level of consciousness due to the patient´s 16 
underlying condition or because of the frequent use of sedation in neuro-critical care 17 
patients. Blood tests are non-specific, in that they may indicate infections of sites other than 18 
the CNS or be elevated due to causes not related to an infection. Finally, changes in CSF 19 
parameters can be concealed by the presence of blood in the CSF space common in ICH, SAH 20 
and TBI patients, making the diagnosis of ERI difficult[34,7].  21 
Positive CSF Gram stains and/or cultures in the context of new clinical signs of CNS infection 22 
plus changes in CSF parameters represent the gold standard for the diagnosis of an EVD-23 
related infection.[35,19] However, Gram stains often are negative even in culture-positive 24 
CSF[31] and CSF cultures take several days until bacterial growth can safely be excluded and 25 
do not allow early diagnosis of infection. Therefore only in a minority of patients a certain 26 
diagnosis of culture proven ERI (CP-ERI) can be made based on evidence for the presence of 27 
bacteria in the cerebrospinal space. Most often clinicians have to base diagnosis and 28 
treatment on clinical features in correlation with changes in blood and CSF parameters 29 
(clinically diagnosed ERI [CD-ERI]). 30 
Recommendations for diagnosis and treatment of ERI represent expert opinion and are 31 
deducted from established criteria for the diagnosis of non-EVD-related central nervous 32 
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system (CNS) infections [34,2,28,35,6,12]. Information on which parameters clinicians base 1 
the diagnosis of EVD-infections is not reported in the literature.  2 
 3 
In this study, we aim to prospectively assess which diagnostic modalities to detect ERI are 4 
most commonly applied by clinicians in the neurocritical care setting. Additionally, we 5 
evaluate the diagnostic accuracy of these parameters in a large cohort of patients.  6 
  7 
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Methods and Materials:  1 
 2 
Study design: Prospective observational multicentre study with a post hoc analysis that 3 
includes a retrospective cohort for comparison.  4 
Setting: Patients were enrolled in the intensive care units (ICU) of the University Hospital of 5 
Bern, Switzerland (centre 1), Royal North Shore Hospital of Sydney (centre 2) and the Alfred 6 
Hospital in Melbourne (centre 3), Australia.  7 
 8 
Participants:  9 
 Prospective Cohort 10 
Consecutive patients over 16 years of age suffering from ICH, SAH or TBI in whom an EVD was 11 
inserted during the study period of 24 months were enrolled in the study (prospective 12 
period). Patients with diagnosed or suspected primary CNS or systemic infection [34] and 13 
patients receiving systemic antibiotic treatment in the 72 hours before EVD placement were 14 
excluded.  15 
 16 
 Retrospective cohort 17 
Because of a very low number of positive CSF cultures and Gram stains in the prospective 18 
cohort, we included a second, retrospective cohort of patients from centre 1 and 2 with 19 
proven ERI. Records of all adult patients older than 16 years of age suffering from ICH, SAH or 20 
TBI in whom an EVD was inserted over a period of five years prior to study commencement 21 
were reviewed. Patients with diagnosed or suspected primary CNS or systemic infection [34] 22 
and patients receiving systemic antibiotic treatment in the 72 hours before EVD placement 23 
were not included in the retrospective cohort.  24 
 25 
Data sources: Collected baseline characteristics in both cohorts included patient 26 
demographics, main diagnosis, Glasgow Coma Score (GCS), Hunt & Hess[21]and Fisher[11] 27 
grading systems for SAH and ICH score[17] for ICH at ICU admission, length of hospital stay 28 
(LOS), survival at hospital discharge and Glasgow Outcome Score (GOS). Clinical data included 29 
clinical signs of a systemic inflammatory response syndrome (SIRS) (temperature >38.3 °C or 30 
<36 °C, heart rate >90 beats/min, respiratory rate >20 breaths/min or PaCO2 < 32 mmHg), 31 
and of CNS infection (nuchal rigidity, headache, and changes in mental status). In the case of 32 
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sedated patients where conclusive assessment of neurological status was not possible, signs 1 
of CNS infection were rated as absent. Laboratory data included all available measurements 2 
of red blood count (RBCC), serum WBCC count, serum C-reactive protein (CRP) level, CSF 3 
RBCC, CSF WBCC, CSF Gram stain and CSF cultures. Blood tests were performed on a daily or 4 
alternate-day basis and CSF samples were regularly (every 24 to 72h) collected from the day 5 
of EVD placement as per routine care. For data collection and statistical analysis, the day of 6 
EVD insertion was defined as day 0. Patient records were matched with the microbiology 7 
database of all cultured microorganisms in CSF and all positive Gram stains of CSF to identify 8 
patients with proven EVD-related infections during the course of the hospital stay. In the 9 
prospective cohort, the experience level of the person placing the EVD and aspects of surgical 10 
technique, the type of antibiotic strategy used, and the duration of catheter use were also 11 
collected.  12 
 13 
Diagnosis of ERI: In the prospective cohort, the treating clinicians had to fill out a 14 
questionnaire to report occurrence of CD-ERI or non-EVD related infections and subsequent 15 
antibiotic treatment. Physicians were required to indicate on which of the following 16 
parameters the diagnosis suspicion had been based: serum WBCC, percentage of blood WBC 17 
band forms, serum CRP levels, CSF cell count, CSF RBCC/WBCC ratio, presence of positive SIRS 18 
criteria and/or clinical signs of CNS infection. 19 
 20 
In both cohorts, CP-ERI was defined as occurrence of a positive CSF culture or Gram stain and 21 
concomitant occurrence of at least two SIRS criteria (temperature >38.3 °C or <36 °C, heart 22 
rate >90 beats/min, respiratory rate >20 breaths/min or PaCO2 < 32 mmHg) or occurrence of 23 
one of any neurological sign of CNS infection (nuchal rigidity, headache, or changes in mental 24 
status) plus increased CSF WBCC[34]. 25 
 26 
Statistical analysis: Data is presented as mean and standard deviation or median and quartiles 27 
as indicated. Normal distribution was established using D'Agostino & Pearson omnibus 28 
normality test.  29 
Fisher´s Test, Chi-square, student´s t-test and Mann-Whitney U test were used to compare 30 
variables of patients with and without CD-ERI in the prospective cohort of study patients. Chi 31 
Square test was used to detect a significant correlation between the clinical diagnosis of ERI 32 
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and CP-ERI in the prospective group.  1 
The correlation between clinical signs, blood results or CSF parameters and occurrence of CP-2 
ERI was assessed using data from both, the prospective and retrospective cohort combined. 3 
Patient-days were classified according to their temporal relation to the time point of diagnosis 4 
of CP-ERI as pre-infection, peri-infection (within 48h before and after diagnosis of CP-ERI) and 5 
post-infection (>48h after diagnosis of CP-ERI). Data from pre-infection patient days versus 6 
peri-infection patient days were used to evaluate the predictive value of clinical and 7 
laboratory indicators in predicting CP-ERI. Receiver operating characteristic (ROC) curves 8 
were constructed plotting sensitivity vs. 1-specificity to evaluate the predictive value of 9 
clinical and laboratory indicators in predicting occurrence of culture positive ERI; the results 10 
are reported as area under the ROC curve (AUROC) and significance value.  11 
Additionally, linear mixed-effect models were used to assess temporal changes of parameters 12 
potentially indicating ERI and differences between patients with and without CP-ERI. Results 13 
are reported as F value and significance p. Potential temporal curve changes based on a 7-day 14 
time period before the development of diagnosed infection were assessed by fitting growth 15 
curves up to a third order polynominal as a covariate and occurrence of infection as fixed 16 
effect. In patients in which no CP-ERI occurred, the first 7 days after EVD insertion was used 17 
as comparison period. Statistical significance was determined when p<0,05 (two-sided). All 18 
statistical analyses were performed using IBM SPSS Statistics 24 (SPSS Inc. Chicago, Illinois). 19 
 20 
Ethics approval: The study protocol was reviewed and approved by the relevant institutional 21 
review boards (Ethics Committee Bern, Switzerland; the Alfred Health Ethics Committee, 22 
Melbourne, Australia; and the Hawkesbury Human Research Ethics Committee, Northern 23 
Sydney Central Coast Health, Australia). All procedures were in accordance with the 24 
institutional and national research committees and with the 1964 Helsinki declaration and its 25 
later amendments or comparable ethical standards.  26 
  27 
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Results:  1 
The baseline characteristics of both cohorts, the number of culture or gram stain positive ERIs 2 
and causal organisms are presented in Table 1.  3 
 4 
Clinical diagnosis of EVD-related infection in the prospective cohort:  5 
Thirty-one CD-ERIs  occurred. The main diagnostic parameters on which ERI was based and 6 
technical aspects of EVD placement and are presented in Table 2, in groups stratified by 7 
presence/absence of clinical EVD infection. There was no significant difference in age and LOS 8 
for the presence of CD-ERI. There was no significant correlation of age and LOS and 9 
occurrence of CD-ERI. One hundred and forty-two non-EVD related infections were 10 
diagnosed. Pneumonia was the main other form of infection (78 patients, 54.9%), followed 11 
by bloodstream infection (7 patients, 4.7%). Infections not related to EVD placement had an 12 
onset time of 5.3±4.8 days, while CD-ERIs developed later, although without significant 13 
difference (p=0.134). In 25.4% of EVD-days systemic antibiotics were used, either for 14 
prophylaxis or treatment of CD-ERI or for treatment of other infections. Most patients 15 
received antimicrobial treatment with 3rd or 4th generation cephalosporins, according to local 16 
protocol. 17 
Most physicians used CSF analysis to establish presence of CD-ERI, with CSF WBCC the most 18 
relevant criterion. A combination of more than one criterion was used in 16 cases (45,7%). 19 
Neurological signs of nuchal rigidity and altered consciousness, as well as positive CSF cultures 20 
and CSF changes (elevated CSF protein, elevated CSF lactate and reduced CSF to blood glucose 21 
ratio) were not used as a diagnostic criteria by any physicians. Single-shot antibiotic 22 
prophylaxis for EVD placement was used in 125 patients (66.8%), whereas 62 patients (33.2%) 23 
received continuous prophylactic antibiotics for the duration of EVD drainage. Antimicrobial 24 
empirical treatment choices are summarized in Table 2. There were 414 antibiotic-exposure 25 
days. All patients but one received systemic antimicrobial treatment; none of them were 26 
treated with intraventricular antibiotics and none of the EVDs was antibiotic-coated. 27 
Monotherapy was only used in 7 patients (20%). Most frequently, antimicrobial combinations 28 
included dual therapy with glycopeptide plus carbapenem (20%) and triple therapy with 29 
cephalosporin plus metronidazol plus glycopeptide (20%).  30 
 31 
 One hundred and sixteen EVD days were counted in the prospective cohort. Episodes of 32 
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abnormal temperature occurred 503 times (31.1% of EVD days), increased heart rate and 1 
respiratory rate were present in 690 (42.7%) and 624 (38.6%) episodes, respectively. 2 
Incidence for signs and symptoms of central nervous system infection was: 21 episodes (1.3%) 3 
of nuchal rigidity; 150 episodes (9.3%) of decreased mental status; and 187 episodes (11.6%) 4 
of headache. A total of 553 episodes (34.2%) of two or more positive SIRS criteria occurred. 5 
The range and incidence of pathological results of potential indicators of ERI are summarized 6 
in Table 3. Finally, the Chi Square test did not reveal a significant correlation between the 7 
clinical diagnosis of ERI and proven CSF infection in the prospective cohort (p=0.0580). 8 
 9 
Prediction of CP-ERI using clinical features and blood and CSF parameters using both cohorts:  10 
A total of 46 CP-ERI occurred in the two study cohorts (7 in the prospective and 39 in the 11 
retrospective cohort). The CP-ERI rate was 4.33 cases per 1000 catheter-days in the 12 
prospective cohort. The ROC analysis of potential clinical indicators of EVD infection revealed 13 
an AUROC of 0.575 (95%-CI 0.5194 - 0.6307, p= 0.0047) for the number of positive SIRS 14 
criteria, and an AUROC 0.5420 (95%-CI 0.4880 - 0.5960, p= 0.11) for the number of 15 
pathological neurological signs. Figure 1 shows the results of the ROC analysis of laboratory 16 
data potentially indicating EVD-related infections. S-WBCC, CSF WBCC and CSF RBCC/WBCC 17 
ratio revealed an AUC of significantly >0.5. Table 4 reports the temporal trends of single 18 
potential predictors of ERI in groups stratified by the presence/absence of proven ERI. No 19 
significant temporal trend in potential predictors of CP-ERI was found during the 7 days prior 20 
to culture or gram stain proven ERI, indicating that no significant increase in number of SIRS 21 
criteria and neurological signs of CNS infection occurred nor higher levels of S-CRP or 22 
increases in S-WBCC, CSF WBCC and CSF WBCC/RBCC ratio were measured in the lead up to 23 
CP_ERI Patients without CP-ERI showed significant changes of SIRS criteria and S-CRP over 24 
time during the first 7 days after EVD placement.  25 
  26 
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Discussion: 1 
In our multicentre observational study, clinicians based their diagnosis of ERI mostly on CSF 2 
analysis and the occurrence of fever. The frequency of CD-ERI was considerably higher than 3 
the incidence of CP-ERI and the two were not correlated. Our analysis indicates that 4 
commonly used diagnostic parameters have a low sensitivity and specificity for detection of 5 
ERI.  6 
 7 
There are several limitations to our study. Because of the low number of CP-ERI in our 8 
prospective sample, we needed to use a retrospective cohort. This may introduce 9 
heterogeneity in the study population and entails the use of a more complex methodology 10 
and statistical analysis. In order to minimize this bias, we identified the retrospective cohort 11 
using the same inclusion and exclusion criteria and baseline characteristics as for our 12 
prospective group. Additionally, the parameters used in the study analysis consist of 13 
laboratory values, defined measurements of vital signs included in the SIRS criteria and signs 14 
of CNS infection which are all routinely and prospectively assessed in all neuro-critical care 15 
patients. It can be assumed that these parameters are measured with the same precision in 16 
the prospective and retrospective cohort. Another important limitation was that data were 17 
restricted to parameters collected in the clinical context. This resulted in missing values and 18 
did not include more recently established infection markers, such as sTREM-1[13], for 19 
determining ERI. We used positive CSF culture or gram stain results as the gold standard 20 
diagnosis of ERI, but this might be associated with a bias caused by the suboptimal sensitivity 21 
and specificity of CSF gram stains and cultures for diagnosing EVD-related infection. Culture 22 
results can be impaired by concomitant antibiotic treatment, that was present in our patient 23 
cohort, during 25% of EVD-days (either for prophylaxis of ERI, treatment of ERI or treatment 24 
of concomitant infection). Nevertheless, we believe that our analysis is valuable and has 25 
several strengths: on the one hand, the trial included a large cohort of patients with EVDs; on 26 
the other hand, the focus of the study was on evaluating how the diagnosis of ERIs established 27 
in the context of current guidelines [34,19,12], which are mostly based on expert opinion, 28 
therefore justifying the need for a further analysis.  29 
 30 
Timely diagnosis and the commencement of adequate antimicrobial therapy is key in 31 
improving patients’ outcomes in ERIs and prompts clinicians to start empiric antibiotic 32 
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therapy in patients in whom ERI is suspected. Several authors [19,8,29] argue that only 1 
positive CSF cultures, in conjunction with CSF pleocytosis, low glucose level, or high protein 2 
level, reliably indicate EVD-related infection. In the absence of positive cultures, some 3 
researchers accept CSF pleocytosis alone as sufficient evidence of CSF infections [32,22]. 4 
However, other authors report that determining ERI based on CSF direct examination has 5 
been shown to have low sensitivity[35,36] and that CSF culture results are not readily 6 
available and not reliable. Our results indicate that clinicians base their diagnosis of EVD 7 
infection mainly on the presence of fever and increased CSF WBC counts. But such a diagnosis 8 
based on clinical and CSF criteria may be misleading: firstly, in the neurocritical population, 9 
SIRS criteria and pathological neurological findings can be a manifestation of the underlying 10 
disease or be influenced by concomitant treatment, such as sedation. Secondly, any type of 11 
systemic infection induces systemic inflammation and can lead to increased levels of CRP and 12 
serum WBCC and concurrent infections occur frequently. Finally, the presence of 13 
intraventricular blood can distort the typical CSF WBC/RBC ratio and be a non-infectious 14 
source of fever. 15 
 16 
In our data, the number of positive SIRS criteria was significantly higher after the occurrence 17 
of proven infection, whereas the number of pathological neurological signs did not differ. The 18 
perceived lack of specificity for CD-ERI might explain why these clinical and laboratory 19 
indicators of infection were used less frequently for diagnosis of ERI.  20 
 21 
Although retrospective data[13,14,37,30,5] have suggested that CSF WBCC and CSF 22 
WBCC/RBCC ratio are useful in the diagnosis of EVD-related infection, our analysis suggests 23 
that commonly used bedside clinical and laboratory parameters are not a reliable basis to 24 
diagnose or exclude ERIs. Occurrence of positive SIRS criteria and of neurological signs of 25 
infection did not sufficiently discriminate between states of confirmed or absent culture-26 
proven EVD infection. We were not able to identify any cut-offs for serum or CSF parameters 27 
that were associated with acceptable sensitivity and specificity to be of value in the clinical 28 
context. Analysing serum or CSF levels of potential indicators of ERI over time – as opposed 29 
to using specific cut-off values – revealed a high inter-individual variability between 30 
measurements; and occurrence of CP-ERI was not associated with any significant temporal 31 
changes of diagnostic markers. Remarkably, only a third of the patients with proven ERI had 32 
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an elevated temperature. Typical neurological symptoms of ERI - such as headache, neck 1 
stiffness or decreased were only reported in 10% of patients. This might reflect the nature of 2 
device-associated infections, which are frequently caused by slow-replicating microorganisms 3 
of low virulence growing in biofilms, such as CoNS (Coagulase-Negative Staphylococci) and 4 
Propionibacterium acnes. 5 
 6 
In accordance with other studies [7,26,37,8,28,2], the most common pathogens were CoNS. 7 
The spectrum of these microorganisms suggests that the patient´s skin flora is an important 8 
source of EVD infection. The type of antibiotic prophylaxis (periprocedural vs continuous) did 9 
not influence the incidence of EVD-related infections. In most patients receiving antimicrobial 10 
prophylaxis before EVD placement, the chosen regimes did not cover the cultured pathogen 11 
spectrum. The use of broad-spectrum penicillins and 2nd generation cephalosporins does not 12 
show adequate coverage of Staphylococcus epidermidis[33], the main pathogenic agent of 13 
this group. Another important aspect is that the isolation of S. epidermidis and other CoNS in 14 
the CSF needs to be interpreted with caution, as this may represent contamination [20]. An 15 
analysis to explore if antibiotic treatment previous to EVD insertion protects against infection 16 
would be interesting and may have clinical consequences, but our data is very small for this 17 
exploratory analysis and we suggest it to be investigated with other studies. 18 
 19 
Our study therefore raises the discussion that routine CSF analysis on a daily basis or at two 20 
day intervals is questionable, although it is the standard practice in most neuro-critical care 21 
units. CSF culture is the only diagnostic parameter with a high specificity, but its sensitivity 22 
impaired by antibiotic use so a restrictive antibiotic strategy for ERI and other infection could 23 
become a trend. We agree that if CSF infection is suspected, CSF cultures should be performed 24 
and empirical antibiotic treatment should be commenced, but treatment should be stopped 25 
immediately once cultures come back negative. 26 
 27 
Because CSF parameters are difficult to interpret, others sources for laboratorial diagnosis 28 
should be sought. Promising other biomarkers of CSF infection already exist[13], but he 29 
specificity/sensitivity of these has not been assessed yet in patients treated with an EVD. 30 
 31 
In conclusion, clinicians base their diagnosis of ERI mostly on CSF analysis and occurrence of 32 
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fever. The frequency of clinically diagnosed ERI is considerably higher than the incidence of 1 
proven ERI and the accuracy of the clinical diagnosis is low. This might lead to frequent use of 2 
antibiotic treatment, causing an increase in risk of inducing growth of antibiotic-resistant 3 
pathogens and impair the sensitivity of CSF cultures. Our analysis indicates that commonly 4 
used clinical and laboratory diagnostic criteria have a low sensitivity and specificity for 5 
detection of EVD-related infection, therefore routine analysis of CSF samples to screen 6 
patients for ERI does not seem to be justified. 7 
 8 
Compliance with ethical standards 9 
 10 
No funding was received for this research. 11 
 12 
All authors certify that they have no affiliations with or involvement in any organization or 13 
entity with any financial interest (such as honoraria; educational grants; participation in 14 
speakers' bureaus; membership, employment, consultancies, stock ownership, or other 15 
equity interest; and expert testimony or patent-licensing arrangements), or non-financial 16 
interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in 17 
the subject matter or materials discussed in this manuscript. 18 
 19 
Due to the observational nature of the study, which only used data obtained during routine 20 
care, formal consent is not required. 21 
 22 
This article does not contain any studies with animals performed by any of the authors. 23 
 24 
 25 
  26 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  
- 15 - 
References: 1 
1. Arabi Y, Memish ZA, Balkhy HH, Francis C, Ferayan A, Al Shimemeri A, Almuneef MA (2005) 2 
Ventriculostomy-associated infections: incidence and risk factors. Am J Infect Control 3 
33:137-143 4 
2. Beer R, Lackner P, Pfausler B, Schmutzhard E (2008) Nosocomial ventriculitis and meningitis 5 
in neurocritical care patients. J Neurol 255:1617-1624. doi:10.1007/s00415-008-0059-6 
8 7 
3. Berger C, Schwarz S, Schaebitz WR, Aschoff A, Schwab S (2002) Serum procalcitonin in 8 
cerebral ventriculitis. Crit Care Med 30:1778-1781 9 
4. Bogdahn U, Lau W, Hassel W, Gunreben G, Mertens HG, Brawanski A (1992) Continuous-10 
pressure controlled, external ventricular drainage for treatment of acute 11 
hydrocephalus--evaluation of risk factors. Neurosurgery 31:898-903; discussion 903-12 
894 13 
5. Bota DP, Lefranc F, Vilallobos HR, Brimioulle S, Vincent JL (2005) Ventriculostomy-related 14 
infections in critically ill patients: a 6-year experience. J Neurosurg 103:468-472 15 
6. Cinibulak Z, Aschoff A, Apedjinou A, Kaminsky J, Trost HA, Krauss JK (2016) Current practice 16 
of external ventricular drainage: a survey among neurosurgical departments in 17 
Germany. Acta Neurochir (Wien) 158:847-853. doi:10.1007/s00701-016-2747-y 18 
7. Conen A, Walti LN, Merlo A, Fluckiger U, Battegay M, Trampuz A (2008) Characteristics and 19 
treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a 20 
retrospective analysis over an 11-year period. Clin Infect Dis 47:73-82. 21 
doi:10.1086/588298 22 
8. Dettenkofer M, Ebner W, Els T, Babikir R, Lucking C, Pelz K, Ruden H, Daschner F (2001) 23 
Surveillance of nosocomial infections in a neurology intensive care unit. J Neurol 24 
248:959-964 25 
9. Dey M, Jaffe J, Stadnik A, Awad IA (2012) External ventricular drainage for intraventricular 26 
hemorrhage. Curr Neurol Neurosci Rep 12:24-33. doi:10.1007/s11910-011-0231-x 27 
10. Edwards NC, Engelhart L, Casamento EM, McGirt MJ (2015) Cost-consequence analysis of 28 
antibiotic-impregnated shunts and external ventricular drains in hydrocephalus. J 29 
Neurosurg 122:139-147. doi:10.3171/2014.9.JNS131277 30 
11. Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid 31 
hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9 32 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  
- 16 - 
12. Fried HI, Nathan BR, Rowe AS, Zabramski JM, Andaluz N, Bhimraj A, Guanci MM, Seder 1 
DB, Singh JM (2016) The Insertion and Management of External Ventricular Drains: An 2 
Evidence-Based Consensus Statement : A Statement for Healthcare Professionals from 3 
the Neurocritical Care Society. Neurocrit Care 24:61-81. doi:10.1007/s12028-015-4 
0224-8 5 
13. Gordon M, Ramirez P, Soriano A, Palomo M, Lopez-Ferraz C, Villarreal E, Meseguer S, 6 
Gomez MD, Folgado C, Bonastre J (2014) Diagnosing external ventricular drain-related 7 
ventriculitis by means of local inflammatory response: soluble triggering receptor 8 
expressed on myeloid cells-1. Crit Care 18:567. doi:10.1186/s13054-014-0567-0 9 
14. Grille P, Verga F, Biestro A (2017) Diagnosis of ventriculostomy-related infection: Is 10 
cerebrospinal fluid lactate measurement a useful tool? J Clin Neurosci 45:243-247. 11 
doi:10.1016/j.jocn.2017.07.031 12 
15. Gutierrez-Gonzalez R, Boto GR, Perez-Zamarron A (2012) Cerebrospinal fluid diversion 13 
devices and infection. A comprehensive review. Eur J Clin Microbiol Infect Dis 31:889-14 
897. doi:10.1007/s10096-011-1420-x 15 
16. Hagel S, Bruns T, Pletz MW, Engel C, Kalff R, Ewald C (2014) External ventricular drain 16 
infections: risk factors and outcome. Interdiscip Perspect Infect Dis 2014:708531. 17 
doi:10.1155/2014/708531 18 
17. Hemphill JC, 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC (2001) The ICH score: 19 
a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32:891-897 20 
18. Hoefnagel D, Dammers R, Ter Laak-Poort MP, Avezaat CJ (2008) Risk factors for infections 21 
related to external ventricular drainage. Acta Neurochir (Wien) 150:209-214; 22 
discussion 214. doi:10.1007/s00701-007-1458-9 23 
19. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-24 
associated infection and criteria for specific types of infections in the acute care 25 
setting. Am J Infect Control 36:309-332. doi:10.1016/j.ajic.2008.03.002 26 
20. Humphreys H, Jenks PJ (2015) Surveillance and management of ventriculitis following 27 
neurosurgery. J Hosp Infect 89:281-286. doi:10.1016/j.jhin.2014.12.019 28 
21. Hunt WE, Hess RM (1968) Surgical risk as related to time of intervention in the repair of 29 
intracranial aneurysms. J Neurosurg 28:14-20. doi:10.3171/jns.1968.28.1.0014 30 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  
- 17 - 
22. Kirmani AR, Sarmast AH, Bhat AR (2015) Role of external ventricular drainage in the 1 
management of intraventricular hemorrhage; its complications and management. 2 
Surg Neurol Int 6:188. doi:10.4103/2152-7806.172533 3 
23. Kitchen WJ, Singh N, Hulme S, Galea J, Patel HC, King AT (2011) External ventricular drain 4 
infection: improved technique can reduce infection rates. Br J Neurosurg 25:632-635. 5 
doi:10.3109/02688697.2011.578770 6 
24. Konstantelias AA, Vardakas KZ, Polyzos KA, Tansarli GS, Falagas ME (2015) Antimicrobial-7 
impregnated and -coated shunt catheters for prevention of infections in patients with 8 
hydrocephalus: a systematic review and meta-analysis. J Neurosurg 122:1096-1112. 9 
doi:10.3171/2014.12.JNS14908 10 
25. Kubilay Z, Amini S, Fauerbach LL, Archibald L, Friedman WA, Layon AJ (2013) Decreasing 11 
ventricular infections through the use of a ventriculostomy placement bundle: 12 
experience at a single institution. J Neurosurg 118:514-520. 13 
doi:10.3171/2012.11.JNS121336 14 
26. Kulkarni AV, Drake JM, Lamberti-Pasculli M (2001) Cerebrospinal fluid shunt infection: a 15 
prospective study of risk factors. J Neurosurg 94:195-201. 16 
doi:10.3171/jns.2001.94.2.0195 17 
27. Leverstein-van Hall MA, Hopmans TE, van der Sprenkel JW, Blok HE, van der Mark WA, 18 
Hanlo PW, Bonten MJ (2010) A bundle approach to reduce the incidence of external 19 
ventricular and lumbar drain-related infections. J Neurosurg 112:345-353. 20 
doi:10.3171/2009.6.JNS09223 21 
28. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES, Jr. (2002) Ventriculostomy-related 22 
infections: a critical review of the literature. Neurosurgery 51:170-181; discussion 23 
181-172 24 
29. Mayhall CG, Archer NH, Lamb VA, Spadora AC, Baggett JW, Ward JD, Narayan RK (1984) 25 
Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med 26 
310:553-559. doi:10.1056/NEJM198403013100903 27 
30. Mounier R, Lobo D, Cook F, Fratani A, Attias A, Martin M, Chedevergne K, Bardon J, Tazi 28 
S, Nebbad B, Bloc S, Plaud B, Dhonneur G (2015) Clinical, biological, and 29 
microbiological pattern associated with ventriculostomy-related infection: a 30 
retrospective longitudinal study. Acta Neurochir (Wien) 157:2209-2217; discussion 31 
2217. doi:10.1007/s00701-015-2574-6 32 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  
- 18 - 
31. Neuman MI, Tolford S, Harper MB (2008) Test characteristics and interpretation of 1 
cerebrospinal fluid gram stain in children. The Pediatric infectious disease journal 2 
27:309-313. doi:10.1097/INF.0b013e31815f53ba 3 
32. Pfisterer W, Muhlbauer M, Czech T, Reinprecht A (2003) Early diagnosis of external 4 
ventricular drainage infection: results of a prospective study. J Neurol Neurosurg 5 
Psychiatry 74:929-932 6 
33. The Sanford Guide to Antimicrobial Therapy 2017 (2017). 41st. edn. Antimicrobial 7 
Therapy, Inc., Dallas, TX  8 
34. Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, 9 
Bleck TP, Garton HJ, Zunt JR (2017) 2017 Infectious Diseases Society of America's 10 
Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin 11 
Infect Dis. doi:10.1093/cid/ciw861 12 
35. van de Beek D, Drake JM, Tunkel AR (2010) Nosocomial bacterial meningitis. N Engl J Med 13 
362:146-154. doi:10.1056/NEJMra0804573 14 
36. Viallon A, Desseigne N, Marjollet O, Birynczyk A, Belin M, Guyomarch S, Borg J, Pozetto B, 15 
Bertrand JC, Zeni F (2011) Meningitis in adult patients with a negative direct 16 
cerebrospinal fluid examination: value of cytochemical markers for differential 17 
diagnosis. Crit Care 15:R136. doi:10.1186/cc10254 18 
37. Wiegand J, Hickson L, Merz TM (2016) Indicators of external ventricular drainage-related 19 
infections--a retrospective observational study. Acta Neurochir (Wien) 158:595-601; 20 
discussion 601. doi:10.1007/s00701-016-2709-4 21 
38. Wyler AR, Kelly WA (1972) Use of antibiotics with external ventriculostomies. J Neurosurg 22 
37:185-187. doi:10.3171/jns.1972.37.2.0185 23 
  24 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  
- 19 - 
Tables: 1 
Table 1. Patient demographics, clinical characteristics and types of organisms grown in study 2 
subjects. 3 
 4 
(CSF: Cerebrospinal Fluid, EVD: External Ventricular Drain, GCS: Glasgow Coma Score, GOS: 5 
Glasgow Outcome Score, ICH: Intracranial Haemorrhage, SAH: Subarachnoid Haemorrhage, 6 
TBI: Traumatic Brain Injury) 7 
  8 
Variable Patients enrolled in the 
Prospective Cohort 
n=187 
Patients enrolled in the 
Retrospective Cohort 
n=39 
Male, n (%) 102(54,5) 17(43,6) 
Mean age (years) 53,65±17,99 48,4±16,9 
Reason for EVD placement, 
n (%) 
ICH 
SAH 
TBI 
 
 
48(25,7) 
85(45,5) 
54(28,9) 
 
 
5(12,8) 
20(51,3) 
9(23,1)) 
Neurological findings at 
time of admission  
GCS (mean score ±SD) 
Hunt & Hess Score (median) 
Fisher Scale (median) 
 
 
8,83±4,15 
3 
3 
 
 
9,4±4,7 
3 
4 
LOS (days) 24,8±25,7 (hospital) 16,6±11,9 
(ICU) 
Survival (at discharge) 141(75,4) 32(82,0) 
Outcome (GOS) (median) 3 3 
Number of positive CSF 
cultures  
6 38 
Number of positive CSF 
gram stains 
1 18 
Cultured Organism   
Staphylococcus aureus   4 
Coagulase-negative 
staphylococci (CoNS) 
3 14 
Enterococcus faecalis  4 
Enterobacteriaciae 2 8 
Propionbacterium acnes 1 -- 
Pseudomonas aeruginosa  3 
Acinetobacter spp  7 
Sphingomonas 
paucimobilis 
 1 
Bacillus  1 
 1 
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Table 2: EVD-placement characteristics and parameters for CD-ERI (prospective cohort) 1 
 2 
Variable Patients with 
occurrence of CD-ERI 
n=31 
Patients without 
occurrence of CD-ERI 
n=156 
P Value 
Experience of doctor placing 
EVD 
1 to 10 years 
11 to 25 years 
Over 25 years 
 
 
3(9,7%) 
11(35,5%) 
17(54,8%) 
 
 
11(7,1%) 
67(42,9%) 
78(50,0%) 
0,704 
Location of EVD placement 
Emergency Department 
ICU 
Operating Theatre 
 
12(38,7%) 
1(3,2%) 
18(58,1%) 
 
85(54,5%) 
6(3,8%) 
65(41,7%) 
0,242 
Surgical Technique for EVD 
insertion 
Long-tunnel 
Short-tunnel 
Straight 
 
 
25(80,6%) 
4(12,9%) 
2(6,5%) 
 
 
116(74,4%) 
26(16.7%) 
14(9,0%) 
0,757 
Type of Site Shaving  
(Large Shaving/Small 
Shaving) 
15(48,4%)/16(52,6%) 84(53,8%)/72(46,2%) 0.719 
Number of attempts for 
placement (one/more than 
one) 
24(77,4%)/7(22,6%) 133(85,3%)/23(14,7%) 0,413 
Type of AB prophylaxis used 
(continuous/periprocedural) 
13(41,9%)/18(58,1%) 49(31,4%)/107(68,6%) 0,353 
Choice of diagnostic 
Parameters 
Positive CSF Stain 
Elevated CSF WBC 
Elevated CSF PMN 
Elevated Serum CRP 
Elevated Serum WBC 
Fever 
 
0,7% 
22,5% 
9,2% 
2,8% 
7,0% 
10,6% 
  
Choice of AB treatment     
Penicillin 
Cephalosporin 
Carbapenem 
Glycopeptide 
Metronidazol 
7 (20%) 
17 (48,6%) 
12 (34,2%) 
27 (77,1%) 
10 (28,6%) 
  
  
  
  
(AB: Antibiotic, CD-ERI: clinically diagnosed EVD related infection, CSF: Cerebrospinal Fluid, 3 
CRP: C-Reactive Protein, EVD: External Ventricular Drain, ICU: Intensive Care Unit, PMN: 4 
Polymorphonuclear Neutrophils, WBC: White Blood Cells) 5 
  6 
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 1 
Table 3: Characteristics of different markers used in the diagnosis of CD-ERI (prospective 2 
cohort) 3 
 4 
 5 
CD-ERI: clinically diagnosed EVD related infection, CSF: Cerebrospinal Fluid, CRP: C-Reactive 6 
Protein, PMN: Polymorphonuclear Neutrophils, RBC: Red Blood Cells, WBC: White Blood 7 
Cells) 8 
  9 
 Number 
of 
episodes 
Min. Max. Mean Std. 
Deviation 
Pathological 
findings 
Number of 
episodes 
Serum CRP (mg/L) 687 2 542 79.95 85.021 > 10 mg/L: 571 
(83,1%) 
Serum WBC (cells/ml) 1486 3 3810
0 
5249.
53 
6317.624 >12,000/mL: 
245 (16,5%) 
Serum WBC immature 
bands (%) 
198 0 62 18.56 14.443  
CSF RBC (cells/µL) 944 0 1590
750 
61738
.21 
150651.10
4 
 
CSF WBC (cells/µL) 915 1 4750 113.9
1 
336.063 5 cells/µL: 643 
(70,3%) 
CSF PMN (cells/µL) 689 1 4350 102.2
2 
303.873  
CSF Protein (mg/dL) 146 1 893 47.06 112.307 >45 µg/dL: 35 
(24,0%) 
CSF Lactate (mmol/L) 505 0 13 2.80 1.258 >4 mmol/L: 74 
(4,6%) 
CSF pH  199 7 9 8.01 .290  
CSF Glucose (mmol/L) 441 1 8 4.13 .961  
Serum Glucose 
(mmol/L) 
1438 3 22 8.19 2.171  
CSF/Serum Glucose 
Ratio 
398 .20 1.67 .5437 .15998 <0.5: 130 
(32,7%) 
CSF WBC/RBC Ratio 898 .00 1.00 .0181 .07046 >0,01: 229 
(25,5%) 
 1 
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Table 4: Analysis for temporal trends of single potential predictors of ERI in groups stratified by presence/absence of CP-ERI (combined data 
from both cohorts). The table describes if a linear, square and cubic increase in number or levels of parameters occurs in the lead up of CP-ERI 
or during the first 7 days after EVD placement (patients without occurrence of CP-ERI), model parameters are reported as weighing factor F 
and respective significance level. 
 
 
  SIRS criteria Neurological 
signs 
S-CRP S-WBCC CSF WBCC CSF WBCC/RBCC 
ratio 
  F p F p F p F p F p F p 
CP-ERI 
(n=180) 
Time 3.112 0.079 0.237 0.627 0.227 0.634 0.061 0.805 0.002 0.960 0.113 0.737 
Time2 3.767 0.053 0.000 0.995 0.085 0.772 0.049 0.825 0.038 0.846 0.200 0.655 
Time3  2.783 0.096 0.004 0.952 0.178 0.674 0.002 0.967 0.220 0.639 0.016 0.901 
No CP-
ERI 
(n=46) 
Time 5.205 0.023 0.082 0.775 21.355 0.000 0.459 0.498 0.459 0.498 1.444 0.230 
Time2 2.219 0.137 0.949 0.330 5.724 0.017 0.299 0.584 0.299 0.584 1.454 0.228 
Time3  1.475 0.225 1.460 0.227 1.407 0.236 0.162 0.688 0.162 0.688 1.531 0.216 
(CP-ERI: culture-proven EVD related infection) CSF: Cerebrospinal Fluid, EVD: External Ventricular Drain, PMN: Polymorphonuclear Neutrophils, 
RBCC: Red Blood Cell Count, S-CRP: Serum C-Reactive Protein, SIRS: Systemic Inflammatory Response Syndrome, S-WBCC: Serum White Blood 
Cell Count) 
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Figure 1. ROC Curves for serum and CSF parameters used for diagnosis of ERI (combined 1 
data from both cohorts). 2 
 3 
 4 
Legend 1: Illustration of the ROC curves for serum parameters [white blood cell count (S-5 
WBCC) and serum C-reactive Protein (S-CRP)] (upper plot) and CSF parameters [CSF 6 
WBCC/RBCC Ratio and CSF white blood cell count (CSF WBCC)] (lower plot). S-WBCC: AUC 7 
0.596 (95% CI 0.538 - 0.654); p=0.0006, S-CRP: AUC 0.550 (95% CI 0.465 - 0.634), p=0.2489; 8 
CSF WBCC/RBCC ratio: AUC 0.690 (95% CI 0.626 - 0.753), p< 0.0001; CSF WBCC: AUC 0.644 9 
(95% CI 0.576 to 0.711), p< 0.0001.  10 
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